DANCR and neoplasm: A large number of studies have reported that targeted inhibition of DANCR, SLCO4A1-AS1, Linc00337, SNHG7/20, NEAT1, MALAT1, ES1 or MALAT1 can reduce the degree of malignancy of tumours at the cellular level and even in animal models.